One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trialMasahiro Natsuaki, Takeshi Kimura, Hisayuki Okada et al.|Cardiovascular Intervention and Therapeutics|2015Cited by 76